| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |